Online inquiry

IVTScrip™ mRNA-Human ASCC1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK25102MR)

This product GTTS-WK25102MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ASCC1 protein. This product can be used in Mitotic arrest phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001198798.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 51008
UniProt ID Q8N9N2
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ASCC1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK25102MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK26847MR IVTScrip™ mRNA-Human ARL6IP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARL6IP1
GTTS-WK19737MR IVTScrip™ mRNA-Human ANKRD9, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD9
GTTS-WK22994MR IVTScrip™ mRNA-Human ASB11, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ASB11
GTTS-WK22064MR IVTScrip™ mRNA-Human ARNTL2, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARNTL2
GTTS-WK20026MR IVTScrip™ mRNA-Human ANKRD44, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD44
GTTS-WK26827MR IVTScrip™ mRNA-Human ARID5A, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARID5A
GTTS-WK3912MR IVTScrip™ mRNA-Human CYR61, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA CYR61
GTTS-WK19705MR IVTScrip™ mRNA-Human ANKRD18DP, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD18DP
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW